{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:38:18Z","timestamp":1747204698686,"version":"3.40.5"},"posted":{"date-parts":[[2023,5,11]]},"group-title":"In Review","reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,4,24]]},"abstract":"<title>Abstract<\/title>\n        <p>Eradication of MRSA osteomyelitis requires elimination of distinct biofilms.  To overcome this, we developed bisphosphonate-conjugated sitafloxacin (BCS, BV600072) and hydroxybisphosphonate-conjugate sitafloxacin (HBCS, BV63072), which achieve \u201ctarget-and-release\u201d drug delivery proximal to the bone infection and have prophylactic efficacy against MRSA static biofilm in vitro and in vivo.  Here we evaluated their therapeutic efficacy in a murine 1-stage exchange femoral plate model with bioluminescent MRSA (USA300LAC::lux).  Osteomyelitis was confirmed by CFU on the explants and longitudinal bioluminescent imaging (BLI) after debridement and implant exchange surgery on day 7, and mice were randomized into seven groups: 1) Baseline (harvested at day 7, no treatment); 2) HPBP (bisphosphonate control for BCS) + vancomycin; 3) HPHBP (bisphosphonate control for HBCS) + vancomycin; 4) vancomycin; 5) sitafloxacin; 6) BCS + vancomycin; and 7) HBCS + vancomycin.  BLI confirmed infection persisted in all groups except for mice treated with BCS or HBCS + vancomycin. Radiology revealed catastrophic femur fractures in all groups except mice treated with BCS or HBCS + vancomycin, which also displayed decreases in peri-implant bone loss, osteoclast numbers, and biofilm.  To confirm this, we assessed the efficacy of vancomycin, sitafloxacin, and HBCS monotherapy in a transtibial implant model.  The results showed complete lack of vancomycin efficacy, while all mice treated with HBCS had evidence of infection control, and some had evidence of osseous integrated septic implants, suggestive of biofilm eradication.  Taken together these studies demonstrate that HBCS adjuvant with standard of care debridement and vancomycin therapy has the potential to eradicate MRSA osteomyelitis.<\/p>","DOI":"10.21203\/rs.3.rs-2856287\/v1","type":"posted-content","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:43:00Z","timestamp":1683852180000},"source":"Crossref","is-referenced-by-count":0,"title":["Evidence of Bisphosphonate-Conjugated Sitafloxacin Eradication of Established Methicillin-Resistant S. aureus Infection with Osseointegration in Murine Models of Implant-Associated Osteomyelitis"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-2506","authenticated-orcid":false,"given":"Chao","family":"Xie","sequence":"first","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youliang","family":"Ren","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Weeks","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Xue","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Rainbolt","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-1111","authenticated-orcid":false,"given":"Karen de Mesy","family":"Bentley","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Shu","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Liu","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-624X","authenticated-orcid":false,"given":"Elysia","family":"Masters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Cherian","sequence":"additional","affiliation":[{"name":"BioVinc, LLC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"McKenna","sequence":"additional","affiliation":[{"name":"BioVinc, LLC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Neighbors","sequence":"additional","affiliation":[{"name":"Pennsylvania State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-1360","authenticated-orcid":false,"given":"Frank","family":"Ebetino","sequence":"additional","affiliation":[{"name":"BioVinc LLC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-9698","authenticated-orcid":false,"given":"Edward","family":"Schwarz","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Sun","sequence":"additional","affiliation":[{"name":"BioVinc, LLC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jor.24804","article-title":"The AO trauma CPP bone infection registry: Epidemiology and outcomes of Staphylococcus aureus bone infection","volume":"39","author":"Morgenstern M","year":"2021","unstructured":"Morgenstern, M. et al. The AO trauma CPP bone infection registry: Epidemiology and outcomes of Staphylococcus aureus bone infection. J Orthop Res 39, 136\u2013146, doi:10.1002\/jor.24804 (2021).","journal-title":"J Orthop Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41413-019-0061-z","article-title":"Evolving concepts in bone infection: redefining \"biofilm\", \"acute vs. chronic osteomyelitis\", \"the immune proteome\" and \"local antibiotic therapy\"","volume":"7","author":"Masters EA","year":"2019","unstructured":"Masters, E. A. et al. Evolving concepts in bone infection: redefining \"biofilm\", \"acute vs. chronic osteomyelitis\", \"the immune proteome\" and \"local antibiotic therapy\". Bone Res 7, 20, doi:10.1038\/s41413-019-0061-z (2019).","journal-title":"Bone Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41579-022-00686-0","article-title":"Skeletal infections: microbial pathogenesis, immunity and clinical management","volume":"20","author":"Masters EA","year":"2022","unstructured":"Masters, E. A. et al. Skeletal infections: microbial pathogenesis, immunity and clinical management. Nat Rev Microbiol 20, 385\u2013400, doi:10.1038\/s41579-022-00686-0 (2022).","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-022-00396-0","article-title":"Fracture-related infection","volume":"8","author":"Moriarty TF","year":"2022","unstructured":"Moriarty, T. F. et al. Fracture-related infection. Nat Rev Dis Primers 8, 67, doi:10.1038\/s41572-022-00396-0 (2022).","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/jor.22672","article-title":"Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters","volume":"32","author":"Varrone JJ","year":"2014","unstructured":"Varrone, J. J. et al. Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters. J Orthop Res 32, 1389\u20131396, doi:10.1002\/jor.22672 (2014).","journal-title":"J Orthop Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e1008988","DOI":"10.1371\/journal.ppat.1008988","article-title":"Identification of Penicillin Binding Protein 4 (PBP4) as a critical factor for Staphylococcus aureus bone invasion during osteomyelitis in mice","volume":"16","author":"Masters EA","year":"2020","unstructured":"Masters, E. A. et al. Identification of Penicillin Binding Protein 4 (PBP4) as a critical factor for Staphylococcus aureus bone invasion during osteomyelitis in mice. PLoS Pathog 16, e1008988, doi:10.1371\/journal.ppat.1008988 (2020).","journal-title":"PLoS Pathog"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jor.24616","article-title":"Adjuvant antibiotic-loaded bone cement: Concerns with current use and research to make it work","volume":"39","author":"Schwarz EM","year":"2021","unstructured":"Schwarz, E. M. et al. Adjuvant antibiotic-loaded bone cement: Concerns with current use and research to make it work. J Orthop Res 39, 227\u2013239, doi:10.1002\/jor.24616 (2021).","journal-title":"J Orthop Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms","volume":"60","author":"Sedghizadeh PP","year":"2017","unstructured":"Sedghizadeh, P. P. et al. Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms. J Med Chem 60, 2326\u20132343, doi:10.1021\/acs.jmedchem.6b01615 (2017).","journal-title":"J Med Chem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060732","article-title":"Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid","volume":"10","author":"Adjei-Sowah E","year":"2021","unstructured":"Adjei-Sowah, E. et al. Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid. Antibiotics (Basel) 10, doi:10.3390\/antibiotics10060732 (2021).","journal-title":"Antibiotics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"910970","DOI":"10.3389\/fcimb.2022.910970","article-title":"Efficacy of Bisphosphonate-Conjugated Sitafloxacin in a Murine Model of S. aureus Osteomyelitis: Evidence of \"Target & Release\" Kinetics and Killing of Bacteria Within Canaliculi","volume":"12","author":"Ren Y","year":"2022","unstructured":"Ren, Y. et al. Efficacy of Bisphosphonate-Conjugated Sitafloxacin in a Murine Model of S. aureus Osteomyelitis: Evidence of \"Target & Release\" Kinetics and Killing of Bacteria Within Canaliculi. Front Cell Infect Microbiol 12, 910970, doi:10.3389\/fcimb.2022.910970 (2022).","journal-title":"Front Cell Infect Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00422-18","author":"Trombetta RP","year":"2018","unstructured":"Trombetta, R. P., Dunman, P. M., Schwarz, E. M., Kates, S. L. & Awad, H. A. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants. mSphere 3, doi:10.1128\/mSphere.00422-18 (2018)."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24293","author":"Schwarz EM","year":"2018","unstructured":"Schwarz, E. M. et al. 2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions. J Orthop Res 37, 997\u20131006, doi:10.1002\/jor.24293 (2019)."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2106\/JBJS.20.01214","article-title":"Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community","volume":"103","author":"Metsemakers WJ","year":"2021","unstructured":"Metsemakers, W. J. et al. Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community. J Bone Joint Surg Am 103, 4\u20139, doi:10.2106\/JBJS.20.01214 (2021).","journal-title":"J Bone Joint Surg Am"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/jor.23801","article-title":"Immunotherapy synergizes with debridement and antibiotic therapy in a murine 1-stage exchange model of MRSA implant-associated osteomyelitis","volume":"36","author":"Yokogawa N","year":"2018","unstructured":"Yokogawa, N. et al. Immunotherapy synergizes with debridement and antibiotic therapy in a murine 1-stage exchange model of MRSA implant-associated osteomyelitis. J Orthop Res 36, 1590\u20131598, doi:10.1002\/jor.23801 (2018).","journal-title":"J Orthop Res"},{"key":"ref15","first-page":"96","article-title":"Antibiotic-loaded acrylic cement: current concepts","author":"Buchholz HW","year":"1984","unstructured":"Buchholz, H. W., Elson, R. A. & Heinert, K. Antibiotic-loaded acrylic cement: current concepts. Clin. Orthop. Relat. Res., 96\u2013108 (1984).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref16","article-title":"The 2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions","author":"Schwarz EM","year":"2019","unstructured":"Schwarz, E. M. et al. The 2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions. Journal of Orthopaedic Research\u00ae (2019).","journal-title":"Journal of Orthopaedic Research\u00ae"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2018.09.038","author":"Parvizi J","year":"2018","unstructured":"Parvizi, J., Gehrke, T., Mont, M. A. & Callaghan, J. J. Introduction: Proceedings of International Consensus on Orthopedic Infections. J. Arthroplasty, doi:10.1016\/j.arth.2018.09.038 (2018)."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24229","article-title":"The 2018 International Consensus Meeting on Musculoskeletal Infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections","author":"Saeed K","year":"2019","unstructured":"Saeed, K. et al. The 2018 International Consensus Meeting on Musculoskeletal Infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections. J Orthop Res, doi:10.1002\/jor.24229 (2019).","journal-title":"J Orthop Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1096\/fj.09-135467","article-title":"Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues","volume":"23","author":"Cheng AG","year":"2009","unstructured":"Cheng, A. G. et al. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23, 3393\u20133404, doi:10.1096\/fj.09-135467 (2009).","journal-title":"FASEB J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1126\/science.1242255","article-title":"Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death","volume":"342","author":"Thammavongsa V","year":"2013","unstructured":"Thammavongsa, V., Missiakas, D. M. & Schneewind, O. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science 342, 863\u2013866, doi:10.1126\/science.1242255 (2013).","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.2106\/JBJS.CC.17.00154","article-title":"Chronic Osteomyelitis with Staphylococcus aureus Deformation in Submicron Canaliculi of Osteocytes: A Case Report","volume":"8","author":"Bentley Mesy","year":"2018","unstructured":"de Mesy Bentley, K. L., MacDonald, A., Schwarz, E. M. & Oh, I. Chronic Osteomyelitis with Staphylococcus aureus Deformation in Submicron Canaliculi of Osteocytes: A Case Report. JBJS Case Connect 8, e8, doi:10.2106\/JBJS.CC.17.00154 (2018).","journal-title":"JBJS Case Connect"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/jbmr.3055","article-title":"Evidence of Staphylococcus Aureus Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis","volume":"32","author":"Bentley Mesy","year":"2017","unstructured":"de Mesy Bentley, K. L. et al. Evidence of Staphylococcus Aureus Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis. J Bone Miner Res 32, 985\u2013990, doi:10.1002\/jbmr.3055 (2017).","journal-title":"J Bone Miner Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.22203\/eCM.v037a26","article-title":"A. A murine femoral ostectomy model with hardware exchange to assess antibiotic-impregnated spacers for implant-associated osteomyelitis","volume":"37","author":"Trombetta RP","year":"2019","unstructured":"Trombetta, R. P., de Mesy Bentley, K. L., Schwarz, E. M., Kate, S. L. & Awad, H. A. A murine femoral ostectomy model with hardware exchange to assess antibiotic-impregnated spacers for implant-associated osteomyelitis. Eur Cell Mater 37, 431\u2013443, doi:10.22203\/eCM.v037a26 (2019).","journal-title":"Eur Cell Mater"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1111\/bph.15251","article-title":"Bisphosphonates for delivering drugs to bone","volume":"178","author":"Sun S","year":"2021","unstructured":"Sun, S. et al. Bisphosphonates for delivering drugs to bone. Br J Pharmacol 178, 2008\u20132025, doi:10.1111\/bph.15251 (2021).","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030154","author":"Wang H","year":"2018","unstructured":"Wang, H. et al. Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice. Pharmaceutics 10, doi:10.3390\/pharmaceutics10030154 (2018)."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jbmr.3889","article-title":"Targeting Bortezomib to Bone Increases Its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice","volume":"35","author":"Wang H","year":"2020","unstructured":"Wang, H. et al. Targeting Bortezomib to Bone Increases Its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice. J Bone Miner Res 35, 343\u2013356, doi:10.1002\/jbmr.3889 (2020).","journal-title":"J Bone Miner Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bonr.2018.06.007","article-title":"Bisphosphonate conjugation for bone specific drug targeting","volume":"9","author":"Farrell KB","year":"2018","unstructured":"Farrell, K. B., Karpeisky, A., Thamm, D. H. & Zinnen, S. Bisphosphonate conjugation for bone specific drug targeting. Bone Rep 9, 47\u201360, doi:10.1016\/j.bonr.2018.06.007 (2018).","journal-title":"Bone Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"115492","DOI":"10.1016\/j.bone.2020.115492","article-title":"Targeting anti-cancer agents to bone using bisphosphonates","volume":"138","author":"Xing L","year":"2020","unstructured":"Xing, L. et al. Targeting anti-cancer agents to bone using bisphosphonates. Bone 138, 115492, doi:10.1016\/j.bone.2020.115492 (2020).","journal-title":"Bone"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116289","author":"Ebetino FH","year":"2022","unstructured":"Ebetino, F. H. et al. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone 156, 116289, doi:10.1016\/j.bone.2021.116289 (2022)."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jac\/44.1.43","article-title":"Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro","volume":"44","author":"Amorena B","year":"1999","unstructured":"Amorena, B. et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44, 43\u201355, doi:10.1093\/jac\/44.1.43 (1999).","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1439-0450.2006.00962.x","article-title":"Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture","volume":"53","author":"Melchior MB","year":"2006","unstructured":"Melchior, M. B., Fink-Gremmels, J. & Gaastra, W. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture. J Vet Med B Infect Dis Vet Public Health 53, 326\u2013332, doi:10.1111\/j.1439-0450.2006.00962.x (2006).","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020094","author":"Trombetta RP","year":"2019","unstructured":"Trombetta, R. P. et al. Calcium Phosphate Spacers for the Local Delivery of Sitafloxacin and Rifampin to Treat Orthopedic Infections: Efficacy and Proof of Concept in a Mouse Model of Single-Stage Revision of Device-Associated Osteomyelitis. Pharmaceutics 11, doi:10.3390\/pharmaceutics11020094 (2019)."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jor.22907","article-title":"Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors","volume":"33","author":"Nishitani K","year":"2015","unstructured":"Nishitani, K. et al. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors. J Orthop Res 33, 1311\u20131319, doi:10.1002\/jor.22907 (2015).","journal-title":"J Orthop Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jbm.b.31500","article-title":"Differences between bisphosphonates in binding affinities for hydroxyapatite","volume":"92","author":"Lawson MA","year":"2010","unstructured":"Lawson, M. A. et al. Differences between bisphosphonates in binding affinities for hydroxyapatite. J Biomed Mater Res B Appl Biomater 92, 149\u2013155, doi:10.1002\/jbm.b.31500 (2010).","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"G. G. Pharmacology of bisphosphonates","volume":"85","author":"Cremers S","year":"2019","unstructured":"Cremers, S., Drake, M. T., Ebetino, F. H., Bilezikian, J. P. & Russell, R. G. G. Pharmacology of bisphosphonates. Br J Clin Pharmacol 85, 1052\u20131062, doi:10.1111\/bcp.13867 (2019).","journal-title":"Br J Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.4049\/jimmunol.1002794","article-title":"Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo","volume":"186","author":"Thurlow LR","year":"2011","unstructured":"Thurlow, L. R. et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol 186, 6585\u20136596, doi:10.4049\/jimmunol.1002794 (2011).","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1128\/AAC.01003-12","article-title":"In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice","volume":"57","author":"Guo Y","year":"2013","unstructured":"Guo, Y. et al. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Antimicrob. Agents Chemother. 57, 855\u2013863, doi:10.1128\/AAC.01003-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajic.2005.06.006","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections","volume":"33","author":"Kourbatova EV","year":"2005","unstructured":"Kourbatova, E. V. et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 33, 385\u2013391, doi:10.1016\/j.ajic.2005.06.006 (2005).","journal-title":"Am J Infect Control"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1002\/jbm.a.36189","article-title":"Surface topography of silicon nitride affects antimicrobial and osseointegrative properties of tibial implants in a murine model","volume":"105","author":"Ishikawa M","year":"2017","unstructured":"Ishikawa, M. et al. Surface topography of silicon nitride affects antimicrobial and osseointegrative properties of tibial implants in a murine model. J Biomed Mater Res A 105, 3413\u20133421, doi:10.1002\/jbm.a.36189 (2017).","journal-title":"J Biomed Mater Res A"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/jor.20452","article-title":"Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity","volume":"26","author":"Li D","year":"2008","unstructured":"Li, D. et al. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res 26, 96\u2013105, doi:10.1002\/jor.20452 (2008).","journal-title":"J Orthop Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/jor.21500","article-title":"Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression","volume":"30","author":"Xie C","year":"2012","unstructured":"Xie, C. et al. Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression. J Orthop Res 30, 325\u2013333, doi:10.1002\/jor.21500 (2012).","journal-title":"J Orthop Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1749-6632.2009.05210.x","article-title":"Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw","volume":"1192","author":"Li D","year":"2010","unstructured":"Li, D. et al. Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw. Ann N Y Acad Sci 1192, 84\u201394, doi:10.1111\/j.1749-6632.2009.05210.x (2010).","journal-title":"Ann N Y Acad Sci"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1359\/JBMR.050806","article-title":"Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering","volume":"20","author":"Zhang X","year":"2005","unstructured":"Zhang, X. et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 20, 2124\u20132137, doi:10.1359\/JBMR.050806 (2005).","journal-title":"J Bone Miner Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/01913129209074550","article-title":"di Sant'Agnese, P. A. Large block embedding and \u201cpop-off\u201d technique for immunoelectron microscopy","volume":"16","author":"Mesy Jensen KL","year":"1992","unstructured":"de Mesy Jensen, K. L. & di Sant'Agnese, P. A. Large block embedding and \u201cpop-off\u201d technique for immunoelectron microscopy. Ultrastructural pathology 16, 51\u201359 (1992).","journal-title":"Ultrastructural pathology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2856287\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2856287\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T07:21:36Z","timestamp":1697700096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2856287\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":44,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2856287\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41413-023-00287-4","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,5,11]]},"subtype":"preprint"}}